Commercial Excellence in Life Sciences: Why Enterprises are Choosing Specialist Providers

Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping the commercial services landscape with targeted technology, therapeutic-area expertise, modular IP, and AI-enabled innovation designed for speed and precision.

Unlike broad-based integrators, these specialists bring targeted solutions built for complexity in areas such as oncology, rare diseases, and specialty care, which is now essential. By blending therapeutic insights with smart tech and agile delivery, they’re helping sales, marketing, and launch teams move faster, make sharper decisions, and unlock value across the commercial value chain.

Join Everest Group experts as they explore how life sciences commercial services specialists are outpacing traditional integrators. As life sciences enterprises evaluate their provider portfolios, this session will offer timely insights on how specialists compete – and often outperform – larger integrators on agility, depth, and commercial impact.

What questions will the webinar answer?

• • What proprietary IP platforms and accelerators are specialists using to drive automation, analytics, and insight delivery across the commercial value chain?

• • How are gen AI and agentic AI being operationalized within specialist offerings to support sales and field activities, HCP engagement, campaign and brand planning, and patient and provider support?

• • In what ways are specialists embedding domain and therapeutic-area expertise into commercial analytics delivery, and how does this translate to differentiated value in high-complexity markets?

• • What engagement models and sourcing strategies – such as co-innovation, innovative pricing models, consulting/advisory support, and partnership ecosystem – are helping commercial specialists unlock faster ROI for buyers?

Who should attend?

• • Pharmaceutical CXOs and leaders

• • MedTech leaders

• • Procurement & vendor-management leaders

• • IT & digital-strategy leaders